dtw Research, Inc. offers a wide variety of syndicated reports ranging from promotional summaries (SnapShot) to syndicated primary research (Launch-Pad, Message View & Impact Assessment).
Search on any of the following:
- Trade Name
- Therapeutic Category/Sub-Category
- Active Ingredient
- Type of Research
- Use the links to the left or the search box above to explore our published research.
- To request information, click the star () to add research to your cart. (Research you currently have selected will appear as )
- From your cart (in the upper right-hand corner of the page) you are able to submit the request to our sales team who will follow up with you.
5 Most Recent SnapShots
Breast Cancer Prelaunch to Post-Launch Evolution
An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.
Featuring: Afinitor, Oncologics/AntiNeoplastics, Niraparib, Keytruda, Alpelisib, Glembatumumab Vedotin, Gemzar, Perjeta, Faslodex, Halaven, Ibrance, Buparlisib, Varlilumab, Tykerb, Kadcyla
Prostate Cancer Market 2016 Quarterly SnapShot Reports
Summary of Print and Digital Promotions for the Prostate Cancer market in Q1, Q2, Q3, and Q4 2016.
Featuring: Provenge, Jevtana, Eligard, Oncologics/AntiNeoplastics, Trelstar, Zytiga, Firmagon, Xofigo, Lupron Depot Injection, Xtandi
Antithrombotics/Anticoagulants Market 2016 Quarterly SnapShot Reports
Summary of Print and Digital Promotions for the Antithrombotic/Anticoagulant Market for Q1, Q2, Q3, and Q4 of 2016.
Featuring: Effient, Durlaza, Eliquis, Xarelto, Stroke/AntiCoagulants, Brilinta, Kengreal, Pradaxa, Savaysa, Zontivity, Praxbind
Antiemetics/CINV Market 2016 Quarterly SnapShot Reports
Summary of Print and Digital Promotions for the Antiemetics/CINV Market for Q1, Q2, Q3, and Q4 of 2016.
Featuring: AntiEmetics, Sancuso, Emend, Akynzeo, Aloxi, Varubi
Insulin Diabetes Market 2016 Quarterly SnapShot Reports
Summary of Print and Digital Promotions for the Insulin/Injectable Diabetes Market for Q1, Q2, Q3, and Q4 of 2016.
Featuring: Tresiba, Basaglar, Levemir, Humalog, Humulin, LixiLan, Toujeo, Lantus, Diabetes (Injectable/Inhaled)
5 Most Recent Studies
Keytruda (pembrolizumab) - CD Promo Message Recall Tracking Study
Featuring: Melanoma, Keytruda, Metastatic Melanoma (MM)
Fielded Start: 02-09-2015
Fielded End: 04-10-2015
Trulicity CD Promo Message View
Featuring: Diabetes (Type 2), Trulicity, Diabetes (Injectable/Inhaled)
Fielded Start: 02-03-2015
Fielded End: 02-04-2015
Otezla CD Promo Message Recall Study
Featuring: Psoriatic Arthritis (PsA), Biologics for RA/DMARDS, Otezla
Fielded Start: 07-29-2014
Fielded End: 08-08-2014
Tanzeum CD Promo Message Recall Study
Featuring: Diabetes (Type 2), Tanzeum (Formerly Syncria), Diabetes (Injectable/Inhaled)
Fielded Start: 07-31-2014
Fielded End: 08-07-2014
Zohydro ER CD Promo Message Recall Study
Featuring: Zohydro ER, Pain (Chronic), Narcotic/Non-Narcotic Analgesics
Fielded Start: 04-03-2014
Fielded End: 04-11-2014
To learn more, contact us.